“Who Wants to Be a Millionaire?” may be a catchy TV game show, but investing in stocks like Alnylam Pharmaceuticals (NASDAQ: ALNY) could be a more realistic path to becoming a millionaire. Co-founded by MIT professor Phillip Sharp, Alnylam focuses on RNA interference (RNAi) therapies, which have shown promising results. With FDA-approved drugs and a robust pipeline, Alnylam is poised for growth. While the stock comes with a high valuation, its potential for significant returns makes it an attractive investment for patient investors. Consider joining Stock Advisor to explore the 10 best stocks to buy now, excluding Alnylam.

Read more at Nasdaq: Is Alnylam Pharmaceuticals a Millionaire Maker?